Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Psychiatry"
DOI: 10.3389/fpsyt.2022.925442
Abstract: ADHD is a common behavioral syndrome with a heritability of 70–80%. Genome wide sequencing and association studies indicate that ADHD risk variants are distributed across a wide range of allele frequencies and relative risks. Several… read more here.
Keywords: adhd; genome; risk; personalized drug ... See more keywords